ARCHIVES

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

This article is from The Cancer Letter archive.

Vol. 34 No. 03 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

September issue of Business & Regulatory Report included–8 additional pages of industry news.

October 1, 2004

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010